Comparing letrozole alone versus letrozole with levothyroxine for women with PCOS and subclinical hypothyroidism
Official title: Letrozole Alone vs. Letrozole Plus Levothyroxine for Ovulation Induction in Infertile Women With Both (Polycystic Ovary Syndrome) PCOS and Sub-clinical Hypothyroidism.
Run by Al-Azhar University · NCT06041204 · Data updated 2026-11-12
This study is testing if adding levothyroxine to letrozole helps women with PCOS and low thyroid function get pregnant more effectively than letrozole alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 40 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Al-Azhar University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | May 6, 2021 |
| Main results expected | May 30, 2026 |
| Study ends | June 28, 2026 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT06041204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 20-40 with a BMI between 18-35 who have been diagnosed with PCOS and subclinical hypothyroidism and have been infertile for at least one year.
✕Probably not a fit
Patients with known thyroid disease, those on thyroid medications, or those with other significant causes of infertility may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of letrozole alone compared to a combination of letrozole and levothyroxine for inducing ovulation in infertile women diagnosed with both polycystic ovary syndrome (PCOS) and subclinical hypothyroidism. Participants will be randomly assigned to receive either letrozole only or letrozole plus levothyroxine for a maximum of six months or until pregnancy is achieved. The study seeks to determine if the addition of levothyroxine improves ovulation rates and leads to higher pregnancy and live birth rates.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for women with PCOS and subclinical hypothyroidism who are struggling with infertility.
How similar studies have gone: While there have been studies on the individual treatments, this specific combination approach is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age between 20-40 years BMI between 18-35 kg/m2 Meet diagnostic criteria for PCOS based on the Rotterdam consensus criteria and ESHRE/ASRM modifications (2018): Oligo- and/or anovulation Clinical and/or biochemical signs of hyperandrogenism Polycystic ovaries on ultrasound Subclinical hypothyroidism defined as TSH level between 5-10 mIU/L with normal free T4 Infertility duration ≥ 1 year Intact ovaries and uterus, confirmed by physical exam and imaging Normal semen analysis in male partner No tubal or peritoneal factor contributing to infertility Effective contraception if not attempting conception Willing and able to provide informed consent Exclusion Criteria: Known thyroid disease or on thyroid medications Abnormal thyroid function tests other than subclinical hypothyroidism Hyperprolactinemia Presence of other causes of infertility such as: Moderate to severe male factor infertility Bilateral tubal occlusion or peritoneal factors Stage III-IV endometriosis Ovarian failure or insufficiency (high FSH or low AMH) Previous diagnosis of any type of congenital adrenal hyperplasia Uncontrolled diabetes (HbA1C \>8%) History of deep vein thrombosis or thromboembolic events Any contraindication to letrozole or levothyroxine Previous use of letrozole or levothyroxine in past 6 months Current or suspected pregnancy Breastfeeding Inability to comply with treatment and follow-up procedures
Where it's running
-
Al-Hussein University Hospital
Cairo, Egypt Recruiting
Study contacts
- Principal investigator: Muhamed Alhagrasy, M.D. — Al-Azhar University
- Study coordinator: Muhamed Alhagrasy, M.D.
- Email: MuhamedAhmed.216@azhar.edu.eg
- Phone: 01017313413
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blocking RANKL with denosumab to protect ovarian follicles
This trial will test whether giving denosumab, a drug that blocks RANKL, can help protect follicle development in women with infertility who are undergoing assisted reproduction.
-
Effect of a 21-day comprehensive spa program on female infertility
This study tests whether a 21-day spa treatment can impact hormonal profiles and reproductive outcomes in women ages 20-40 with infertility.
-
Endometrial immune profile changes after putting your own PRP into the uterus
This test will try whether putting a person's own platelet-rich plasma (PRP) into the uterus improves the uterine immune profile, thickness, hormone levels, and pregnancy rates for people undergoing IVF with euploid embryo transfer.
-
Day-4 embryo defragmentation to improve blastocyst formation and pregnancy outcomes
This study tests whether removing cytoplasmic fragments from Day-4 morula-stage embryos helps people undergoing ICSI get more blastocysts and better pregnancy chances.
-
PPOS versus GnRH antagonist IVF protocols for women with PCOS
This trial will test whether a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol gives better IVF outcomes for women aged 18–40 with PCOS.
-
Levothyroxine for heart function in children with subclinical hypothyroidism
This trial will test whether levothyroxine improves heart function in children aged 4–15 who have subclinical hypothyroidism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.